1. [Clinical significance of serum miRNA-146, OX-LDL and ROS expression in patients with primary ovarian insufficiency]
- Author
-
Yanhui, Liu, Jia'nan, Liu, Fu, Xiong, Yan, Sun, Jianhua, Luo, Peiqing, He, and Fengping, He
- Subjects
Toll-Like Receptor 4 ,Mice ,MicroRNAs ,NF-kappa B ,Humans ,Animals ,Female ,Apoptosis ,Primary Ovarian Insufficiency ,Reactive Oxygen Species - Abstract
To investigate the clinical significance of miRNA-146, OX-LDL and ROS in patients with primary ovarian insufficiency (POI).100 patients with POI were prospectively collected and 100 women with normal ovarian function were randomly selected as control group. Serum miRNA-146 expression level was detected by qRT-PCR and serum OX-LDL and ROS expression levels were detected by ELISA. Ovarian granulosa cells of mouse were transfected with miRNA-146 mimics or inhibitors, and then treated with OX-LDL. Cell viability, colony forming ability, apoptosis rate and toll like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) of pathway proteins were evaluated respectively.Compared with control group, the expression level of miRNA-146 in POI group was significantly lower, the expression level of OX-LDL and ROS were significantly higher, and the ovarian volume and peak systolic blood flow velocity of ovarian artery were significantly decreased in POI group. Upregulation of miRNA-146 expression had a protective effect on OX-LDL injured ovarian granulosa cells, as evidenced by increased ovarian granulosa cell viability and colony number, reduced apoptosis, and downregulation of TLR4/NF-κB expression.miRNA-146 can target downstream TLR4/NF-κB signaling pathway affects oxidative stress and inflammatory response of POI induced by OX-LDL and ROS, and is expected to become a biomarker for early prediction of POI and a new target for treatment.
- Published
- 2022